Finance

Lists
Why is 688193 down 2.28%?
Dive Deeper
688193:SHA
Shanghai Rendu Biotechnology Co Ltd
CNÂ¥46.32
-2.28%
(-1.08) 1D
Oct 16, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688193...
Open
CNÂ¥47.70
High
CNÂ¥48.50
Low
CNÂ¥45.83
Mkt. cap
1.86B
Avg. vol.
478.86K
Volume
551.35K
Dividend
2.48%
Quarterly dividend
CNÂ¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
95.56
52-wk high
CNÂ¥63.56
52-wk low
CNÂ¥40.00
EPS
CNÂ¥0.48
No. of employees
235
Open
CNÂ¥47.70
High
CNÂ¥48.50
Low
CNÂ¥45.83
Mkt. cap
1.86B
Avg. vol.
478.86K
Volume
551.35K
Dividend
2.48%
Quarterly dividend
CNÂ¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
95.56
52-wk high
CNÂ¥63.56
52-wk low
CNÂ¥40.00
EPS
CNÂ¥0.48
No. of employees
235
News stories
From web sources and news partners
About Shanghai Rendu Biotechnology Co Ltd
CEO-
Employees235
FoundedJun 13, 2007
Headquarters-
SectorMedical device
Websiterdbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
37.91M
42.79M
42.08M
37.36M
Cost of goods sold
7.93M
11.00M
10.01M
7.44M
Cost of revenue
7.93M
11.00M
10.01M
7.44M
Research and development expenses
9.26M
8.39M
6.69M
6.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.41M
30.59M
22.68M
25.63M
Operating expense
23.43M
34.70M
29.53M
31.79M
Total operating expenses
31.36M
45.70M
39.54M
39.24M
Operating income
6.55M
-2.91M
2.54M
-1.88M
Other non operating income
35.50K
-229.22K
-49.46K
50.36K
EBT including unusual items
6.58M
2.88M
5.47M
4.86M
EBT excluding unusual items
8.38M
722.99K
5.91M
3.23M
Income tax expense
1.60M
-196.52K
474.90K
276.18K
Effective tax rate
24.35%
-6.83%
8.68%
5.69%
Other operating expenses
-2.78M
765.60K
-60.22K
-18.26K
Net income
4.98M
3.07M
5.00M
4.58M
Net profit margin
13.12%
7.18%
11.87%
12.26%
Earnings per share
-
-
-
-
Interest and investment income
1.84M
4.01M
3.47M
5.20M
Interest expense
-82.10K
-42.18K
-49.67K
-55.07K
Net interest expenses
1.76M
3.96M
3.42M
5.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
10.08M
457.33K
5.91M
1.42M
Gain or loss from assets sale
7.32K
386.31K
-
-14.90K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps